Search the Newsreel

BioLife Solutions (NASDAQ:BLFS) Hits New 12-Month High - Time to Buy?

BioLife Solutions (NASDAQ:BLFS) recently hit a new 52-week high of $34.93, trading nearly flat at $34.64. The company reported strong quarterly earnings of $0.91 per share, significantly beating the consensus estimate of $0.03, and revenue of $28.47 million, exceeding expectations. Despite insider selling activity …

BioLife Solutions Cut to Hold From Buy by Benchmark

Benchmark downgraded BioLife Solutions (BLFS) stock from Buy to Hold. This adjustment reflects a revised outlook from the firm regarding the company's investment potential.

Why BioLife Solutions (BLFS) Is Up 7.8% After Swinging To Q2 Profitability And What's Next

BioLife Solutions (BLFS) reported a significant swing to profitability in Q2 2026, with sales up to US$28.47 million and net income of US$45.1 million, driven by its role as a supplier to the cell and gene therapy sector. The company is set to be …

BioLife Solutions (BLFS) Is Up 7.2% After Swinging From Loss To Q2 Profit - What's Changed

BioLife Solutions (BLFS) reported a significant turnaround in Q2 2026, swinging from a net loss of US$15.84 million to a net income of US$45.10 million, with sales increasing to US$28.47 million. This improved financial performance follows the announcement of a US$1.6 billion acquisition by …

BioLife Solutions (BLFS) Stock Price Ignores A Sharp Turn To Profit

BioLife Solutions Inc (BLFS) Stock News Today

BioLife Solutions, Inc. reports results for the quarter ended June 30 - Earnings Summary

BioLife Solutions, Inc. has released its earnings summary for the quarter that ended on June 30. The full article provides detailed results of the company's financial performance during this period.

ETFs Investing in BioLife Solutions, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of BioLife Solutions, Inc. (BLFS). The ETFs are primarily focused on small-cap companies and are managed by various financial institutions like BlackRock, State Street Corp., and The Vanguard Group. The provided table includes …

Royal Bank of Canada Purchases 66,010 Shares of BioLife Solutions, Inc. $BLFS

Royal Bank of Canada increased its stake in BioLife Solutions (NASDAQ:BLFS) by 8.1%, purchasing an additional 66,010 shares, bringing its total to 885,298 shares valued at approximately $16.9 million. This transaction comes as other institutional investors have adjusted their positions, and despite a major …

BLFS Looks 16.4% Overvalued on GF Value™ Amid Strong Q2 Revenue Beat

Is BioLife Solutions Inc (BLFS) Overvalued After Q2 Earnings Bea

BLFS SWOT Analysis: Strong Revenue Growth Amidst Strategic Changes Revealed in 10-Q Filing

BioLife Solutions Reports Second Quarter 2026 Financial Results

BioLife Solutions announced its Q2 2026 financial results, reporting total revenue of $28.5 million, a 21% increase over Q2 2025, and GAAP net income of $45.1 million, which included a significant non-cash income tax benefit. The company also confirmed its pending acquisition by Repligen …

BioLife Solutions (NASDAQ: BLFS) plans cash-stock merger with Repligen

BioLife Solutions (NASDAQ: BLFS) has reported strong Q2 2026 financial results, with revenue reaching $28.5 million and net income from continuing operations at $45.1 million, largely due to a significant income tax benefit. The company also announced a cash-and-stock merger agreement with Repligen, where …

Earnings Flash (BLFS) BioLife Solutions, Inc. Reports Q2 Revenue $28.5M, vs. FactSet Est of $27.8M

BioLife Solutions, Inc. (BLFS) announced its Q2 revenue of $28.5 million, surpassing the FactSet estimate of $27.8 million. The company's stock, listed on Nasdaq, closed at $33.93 on August 6th, marking a 0.38% increase for the day. This positive earnings report follows a series …

BIOLIFE SOLUTIONS ($BLFS) Releases Q2 2026 Earnings

BioLife Solutions set to report earnings under takeover cloud

BioLife Solutions is set to report second-quarter earnings under the shadow of a $1.5 billion acquisition agreement by Repligen Corporation. Analysts have largely downgraded BioLife's stock to "Hold" with price targets around the acquisition price of $31 per share. Investors will be focused on …

BioLife Solutions (BLFS) Earnings Date and Reports 2026 $BLFS

BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates

BioLife Solutions (NASDAQ:BLFS) Posts Earnings Results, Beats Estimates By $0.88 EPS

Biolife Solutions stock hits 52-week high at 33.18 USD

BioLife Solutions Inc. (NASDAQ:BLFS) stock recently hit a 52-week high of $33.18, reflecting a 56.33% increase over the past year and a current market capitalization of $1.61 billion. Despite strong revenue growth and analyst predictions of profitability, InvestingPro analysis suggests the stock may be …

Repligen Corporation (BLFS) sets cash and stock terms for BioLife Solutions buyout

Repligen Corporation has entered into an Agreement and Plan of Merger to acquire BioLife Solutions for $11.25 in cash plus 0.1442 shares of Repligen common stock per BioLife share. The transaction is a strategic move in the cell therapy market, pending regulatory and BioLife …

Repligen to acquire BioLife Solutions in two-step merger; employee video details timeline

BioLife Solutions and Repligen are set to merge through a two-step process, forming a Repligen subsidiary, with an expected closing in Q4 pending approvals. The first step involves Repligen's Merger Sub 1 merging into BioLife, making BioLife a direct subsidiary, followed immediately by BioLife …

BioLife Solutions, Inc. Revenue Breakdown – NASDAQ:BLFS

This article provides a revenue breakdown for BioLife Solutions, Inc. (NASDAQ: BLFS). Last year, the company generated $96.21 million USD, with its top-performing segment, Bioproduction Products and Services, contributing the entire amount. The United States was the primary revenue source, accounting for $76.97 million …

BioLife Solutions Inc (BLFS) Valuation: PE, PB & Fair Value Analysis

BioLife Solutions Inc (BLFS) currently has a valuation score of 8.75, placing it 62nd out of 199 in the Healthcare Equipment & Supplies industry. The company's P/E ratio is -508.27, which is significantly below its recent high and slightly above its recent low. Other …

Hsbc Holdings PLC Purchases Shares of 45,576 BioLife Solutions, Inc. $BLFS

HSBC Holdings PLC has acquired 45,576 shares of BioLife Solutions, Inc. (NASDAQ:BLFS) valued at about $874,000, representing a 0.09% stake in the medical equipment provider. Despite the company recently exceeding earnings expectations with $0.04 EPS versus a $0.01 estimate and $27.50 million in revenue, …

BioLife Solutions (BLFS) to Post Earnings on Thursday

U.S. RESEARCH ROUNDUP- BioLife Solutions, Gossamer Bio, Intuit

This article summarizes changes in analyst ratings and price targets for several U.S.-listed companies as reported by Reuters on a Friday. Key changes include Stephens cutting BioLife Solutions to equal weight, Leerink Partners raising Gossamer Bio to outperform, and TD Cowen cutting Intuit to …

BioLife Solutions, Inc. (BLFS) Investor Outlook: Navigating Growth with a 4.9% Upside Potential

BioLife Solutions, Inc. (BLFS) is a healthcare company specializing in medical instruments and supplies for cell and gene therapy, with a market cap of $1.46 billion. Despite a current EPS of -0.24 and negative return on equity due to ongoing investments, analysts project a …

Biolife Solutions stock hits 52-week high at 32.24 USD

Biolife Solutions stock reached a 52-week high of $32.24, showing a significant 34.8% increase over the past year. The company boasts a 1.56 billion USD market cap, nearly 30% revenue growth, and a "GREAT" financial health score from InvestingPro, though its stock may be …

HC Wainwright Expects Higher Earnings for BioLife Solutions

HC Wainwright has increased its Q2 2026 EPS forecast for BioLife Solutions to a loss of $0.01, up from a projected loss of $0.02, while maintaining a Neutral rating and $31 price target. The company reported quarterly EPS of $0.04, surpassing estimates, but insider …

BioLife Solutions Inc (BLFS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for BioLife Solutions Inc (BLFS), detailing its regional revenue contributions. As of April 6, the company generated $76.97 million (80%) from the United States, $13.47 million (14%) from Europe & Middle East & Africa (EMEA), and $5.77 million …

BioLife Solutions, Inc. Revenue Breakdown – GETTEX:BJX1

BioLife Solutions, Inc. (GETTEX: BJX1) reported a total revenue of €81.92 million last year, primarily from its Bioproduction Products and Services segment. The majority of this revenue, €65.53 million, was generated in the United States. The article provides a breakdown of the company's financial …